Top 20 Biotechnology Companies in New Jersey
Top 20 Biotechnology Companies in New Jersey
New Jersey is home to a thriving biotechnology sector that contributes notably to healthcare innovation. This industry features firms specializing in drug development, advanced therapies, and pharmaceutical services. Companies in New Jersey are on the cutting edge of scientific research, addressing complex health challenges ranging from rare diseases to cancer. With technological advancements and ongoing investments, the industry is poised for rapid growth. Public health initiatives and collaborations with academic institutions bolster the state’s position as a hub for biopharmaceutical innovation, reflecting a robust commitment to improving global health outcomes.
The listed companies represent a mix of sizes, from small startups to established firms, all rooted in New Jersey. With founders dating as far back as 1972, these businesses showcase specializations such as plasma-derived therapies, vaccine development, and immuno-oncology research. Many of the firms also maintain strong international ties, extending their reach beyond U.S. borders. Overall, their operational footprints range widely, from 50 employees to over 5,000, indicating a vibrant sector catering to various pharmaceutical needs.
Read on to discover the top biotechnology companies in New Jersey.
Top 20 Biotechnology Companies Companies in New Jersey
1. Kedrion Biopharma
- Website: kedrion.com
- Ownership type: Private Equity
- Headquarters: Fort Lee, New Jersey, United States (USA)
- Employee distribution: Italy 49%, United States (USA) 27%, United Kingdom (UK) 14%, Other 11%
- Latest funding: September 2022
- Founded year: 2001
- Headcount: 1001-5000
- LinkedIn: kedrion-biopharma
Kedrion Biopharma is a biopharmaceutical company founded in 2001, headquartered in Fort Lee, New Jersey. The company specializes in the collection and fractionation of blood plasma to produce and distribute plasma-derived therapies aimed at treating rare and debilitating conditions, including coagulation disorders and immunodeficiencies. With a workforce of over 2,200 employees, Kedrion operates multiple production plants across Europe and North America, and it has established plasma collection centers in the United States and the Czech Republic. The company serves healthcare providers and national health systems, ensuring access to essential medical products. In 2022, Kedrion expanded its capabilities by acquiring Bio Products Laboratory, enhancing its portfolio and market reach. Their commitment to quality, safety, and social responsibility underscores their role as a significant player in the biopharmaceutical industry, particularly in the niche of rare disease therapies.
2. NPS Pharma
- Website: shire.com
- Ownership type: Corporate
- Headquarters: Bedminster, New Jersey, United States (USA)
- Employee distribution: United States (USA) 51%, Algeria 12%, Ireland 12%, Other 25%
- Latest funding: $86.4B, April 2018
- Founded year: 1986
- Headcount: 201-500
- LinkedIn: nps-pharmaceuticals
NPS Pharma, a subsidiary of Takeda Pharmaceutical Company Limited, is based in Bedminster, New Jersey. Founded in 1986, the company specializes in the research, development, and marketing of innovative medicines. NPS Pharma is particularly focused on therapeutic areas such as rare diseases, gastrointestinal diseases, and oncology. Their work aims to address unmet medical needs, providing treatments for conditions that often lack effective options. The company has a strong commitment to advancing science and improving patient outcomes through its robust pipeline of products. NPS Pharma's integration into Takeda has expanded its reach and capabilities, allowing it to leverage Takeda's global resources while maintaining its focus on specialized therapies.
3. CSL Seqirus
- Website: cslseqirus.com
- Ownership type: Private
- Headquarters: Summit, New Jersey, United States (USA)
- Employee distribution: United States (USA) 42%, Netherlands 21%, United Kingdom (UK) 21%, Other 16%
- Founded year: 1916
- Headcount: 1001-5000
- LinkedIn: cslseqirus
CSL Seqirus, based in Summit, New Jersey, is a prominent biotechnology company focused on the development and manufacture of vaccines and therapies for serious diseases. Founded in 1916, the company has a long history of innovation in the healthcare sector. As one of the largest providers of influenza vaccines globally, CSL Seqirus plays a vital role in public health initiatives. Their product offerings include vaccines for seasonal influenza, pandemic response, and other infectious diseases. The company is part of CSL Limited, which also includes CSL Behring and CSL Vifor, and operates with a strong emphasis on research and development. This focus allows them to stay at the forefront of vaccine technology and respond effectively to emerging health threats. With a workforce of over 2,600 employees distributed across multiple countries, CSL Seqirus is committed to improving health outcomes through innovative medical solutions.
4. Anima Biotech
- Website: animabiotech.com
- Ownership type: Corporate
- Headquarters: Bernardsville, New Jersey, United States (USA)
- Employee distribution: Israel 74%, United Arab Emirates 23%, United Kingdom (UK) 3%
- Latest funding: $120.0M, March 2021
- Founded year: 2014
- Headcount: 51-200
- LinkedIn: anima-biotech
Anima Biotech, founded in 2014 and based in Bernardsville, New Jersey, is a biotechnology company focused on developing small molecule mRNA drugs. The company has carved out a niche in the biotechnology sector by leveraging artificial intelligence to enhance drug discovery processes. Their proprietary mRNA Lightning™ platform is notable for its ability to visualize and analyze mRNA biology, having generated over 2 billion images of the mRNA life cycle in cells. This technology allows Anima to conduct millions of automated biology experiments, screening for molecules that can revert diseased cells to a healthy state. Anima's pipeline includes candidates in immunology, oncology, and neuroscience, with ongoing collaborations with major pharmaceutical firms to discover and develop mRNA drugs and vaccines. The company has also attracted significant funding, with a reported amount of $120 million in March 2021, underscoring its potential in the biotechnology field.
5. Porton Advanced | ATMP CDMO/CRO
- Website: portonadvanced.com
- Ownership type: Private Equity
- Headquarters: Cranbury, New Jersey, United States (USA)
- Employee distribution: China 93%, United States (USA) 7%
- Latest funding: Series B, $80.0M, August 2022
- Founded year: 2018
- Headcount: 201-500
- LinkedIn: porton-biologics-ltd
Porton Advanced | ATMP CDMO/CRO, based in Cranbury, New Jersey, is a biopharmaceutical service provider that specializes in cell and gene therapy solutions. Founded in 2018, the company offers a comprehensive suite of services, including vector cloning, plasmid preparation, and viral vector production. Their expertise supports biotech and pharmaceutical companies, academic institutions, and hospitals in the development and commercialization of advanced therapies. Porton Advanced has made significant investments in platform development, focusing on areas such as mRNA, lentivirus, and adeno-associated virus (AAV) technologies. The company operates a GMP-compliant facility and has established a strong presence in the market, with a notable percentage of their workforce located in China. In August 2022, they secured $80 million in Series B funding, which underscores their growth potential and the confidence investors have in their innovative approach to biopharmaceutical services.
6. Celltrion USA
- Website: celltrionusa.com
- Ownership type: Private
- Headquarters: Jersey City, New Jersey, United States (USA)
- Employee distribution: United States (USA) 100%
- Founded year: 2018
- Headcount: 51-200
- LinkedIn: celltrionusa
Celltrion USA, Inc. is a biopharmaceutical company based in Jersey City, New Jersey, founded in 2018. The company is dedicated to improving patient access to high-quality biologics, leveraging its biotechnology heritage to provide advanced therapies within the U.S. healthcare system. Celltrion USA offers a range of products, including Zymfentra™, Yuflyma®, and Vegzelma®, which are designed to meet the needs of patients requiring biologic treatments. The company emphasizes its commitment to patient welfare and strives to enhance healthcare access through its innovative solutions. With a workforce of approximately 93 employees, Celltrion USA is positioned to make a significant impact in the biopharmaceutical landscape, focusing on the development and distribution of biologics that cater to various medical needs.
7. Venenum BioDesign, LLC
- Website: venenumbiodesign.com
- Ownership type: Private
- Headquarters: Hamilton Township, New Jersey, United States (USA)
- Employee distribution: United States (USA) 100%
- Founded year: 2009
- Headcount: 11-50
- LinkedIn: venenum-biodesign-llc
Venenum BioDesign, LLC, based in Hamilton Township, New Jersey, is a biotechnology firm founded in 2009. The company is dedicated to drug discovery and development, with a particular emphasis on creating innovative treatments for unmet medical needs in immuno-oncology and metabolic diseases. Venenum BioDesign operates as a member of the Genesis Biotechnology Group, which provides a collaborative environment for advancing drug discovery initiatives. Their services include assay development, compound optimization, and structural biology, catering primarily to pharmaceutical and biotechnology firms. The company boasts a significant collection of small molecules, utilizing their proprietary ECLiPS technology to enhance the drug discovery process. Venenum's pipeline includes promising research programs targeting STING agonists and MGAT2 inhibitors, showcasing their commitment to addressing critical health issues. They have a proven track record of success in identifying novel chemotypes and advancing compounds into in vivo studies, reflecting their active engagement in the biotechnology industry.
8. Mestastop Solutions
- Website: mestastop.com
- Ownership type: Venture Capital
- Headquarters: Evesham, New Jersey, United States (USA)
- Employee distribution: India 95%, Switzerland 5%
- Latest funding: Seed, $541,000, October 2023
- Founded year: 2018
- Headcount: 11-50
- LinkedIn: mestastop-solutions
Mestastop Solutions, founded in 2018 and based in Evesham, New Jersey, is a biotechnology firm dedicated to cancer research and treatment. The company specializes in innovative solutions aimed at drug discovery, drug repurposing, and clinical translations, with a particular focus on the complexities of cancer metastasis. Their primary clientele includes healthcare providers and pharmaceutical companies seeking advanced research services to enhance cancer treatment outcomes. Mestastop has recently secured seed funding, amounting to over $541,000, which reflects confidence from investors in their approach and technology. The company operates with a significant workforce based in India, complemented by a small presence in Switzerland, and is actively involved in collaborations with various research institutions. Their proprietary platforms, such as METAssay, METVivo, and METSCAN, are designed to dissect metastasis biology and improve the efficacy of cancer treatments, showcasing their commitment to addressing critical challenges in oncology.
9. Janssen Research & Development, LLC
- Website: janssenrnd.com
- Ownership type: Private
- Headquarters: Raritan, New Jersey, United States (USA)
- Employee distribution: United States (USA) 89%, Belgium 3%, Poland 3%, Other 5%
- Founded year: 2001
- Headcount: 1001-5000
- LinkedIn: janssen-research-%26-development-llc
Janssen Research & Development, LLC, based in Raritan, New Jersey, is a pharmaceutical company that specializes in innovative medicine. Founded in 2001, the company is dedicated to developing treatments for serious health conditions across various therapeutic areas, including oncology, immunology, and neuroscience. Janssen is part of Johnson & Johnson, which enhances its capabilities and reach in the healthcare sector. The company actively engages in research and development, focusing on creating advanced medical therapies that address unmet medical needs. With a workforce of over 1,000 employees, Janssen operates primarily in the United States, with a small presence in Belgium, Poland, China, and the United Kingdom. Their commitment to improving patient outcomes is reflected in their extensive pipeline of products and ongoing clinical trials, aimed at delivering transformative therapies to patients worldwide.
10. NS Pharma, Inc.
- Website: nspharma.com
- Ownership type: Private
- Headquarters: Paramus, New Jersey, United States (USA)
- Employee distribution: United States (USA) 95%, Ghana 4%, Other 2%
- Founded year: 1999
- Headcount: 51-200
- LinkedIn: ns-pharma-inc
NS Pharma, Inc., based in Paramus, New Jersey, is a private biopharmaceutical company founded in 1999. The company is dedicated to developing innovative therapies for rare diseases, with a particular emphasis on Duchenne muscular dystrophy (DMD). NS Pharma has made strides in the field with its product VILTEPSO (viltolarsen), an exon-skipping therapy that received accelerated approval from the FDA in 2020. This therapy is designed for patients with a specific mutation of the DMD gene, showcasing the company's focus on precision medicine. NS Pharma operates under the umbrella of Nippon Shinyaku Co., Ltd., which has a long-standing history in the pharmaceutical industry. The company is actively engaged in clinical research and has a pipeline that includes several investigational therapies aimed at improving patient outcomes in DMD and other rare diseases. Their commitment to patient care and community support further underscores their role in the biotechnology sector.
11. Genesis Global Group
- Website: genesisglobalgrp.com
- Ownership type: Private
- Headquarters: Hamilton Township, New Jersey, United States (USA)
- Employee distribution: United States (USA) 100%
- Founded year: 2020
- Headcount: 501-1000
- LinkedIn: genesisglobalgroup
Genesis Global Group, founded in 2020 and based in Hamilton Township, New Jersey, is a private company that operates across several sectors, including biotechnology, health care, manufacturing, real estate, and hospitality. The company aims to provide innovative solutions and services that enhance quality and efficiency for businesses and individuals. Within the biotechnology sector, Genesis Global Group has made strides through its subsidiary, Genesis Drug Discovery & Development (GD3), which focuses on drug discovery and development. They have engaged in strategic acquisitions, such as JSS Medical Research, to expand their clinical services portfolio. Additionally, their partnership with Yale University highlights their commitment to advancing biotechnology research and development. Despite their involvement in biotechnology, the company's broad operational scope may overshadow its specific contributions to the field.
12. Kedrion Biopharma US
- Website: kedrion.us
- Ownership type: Family Owned
- Headquarters: Fort Lee, New Jersey, United States (USA)
- Employee distribution: United States (USA) 97%, Other 3%
- Founded year: 2011
- Headcount: 1001-5000
- LinkedIn: bio-products-laboratory-usa-inc.
Kedrion Biopharma US, headquartered in Fort Lee, New Jersey, is a biopharmaceutical company that focuses on the production and distribution of plasma-derived therapeutic products. Founded in 2011, the company has quickly established itself in the biotechnology sector by addressing serious health conditions such as hemophilia and primary immune deficiencies. Kedrion operates with a strong emphasis on quality and safety, ensuring that their products meet rigorous standards. Their operations include extensive research and development efforts aimed at creating new therapies and improving existing ones. Kedrion is also involved in community support initiatives, reflecting their commitment to the welfare of patients and healthcare providers. With a presence in approximately 100 countries, Kedrion is dedicated to fostering self-sufficiency in plasma-derived products and enhancing the quality of life for individuals suffering from rare disorders.
13. DavosPharma
- Website: davos.com
- Ownership type: Private
- Headquarters: Upper Saddle River, New Jersey, United States (USA)
- Employee distribution: United States (USA) 100%
- Founded year: 1972
- Headcount: 11-50
- LinkedIn: davospharma
DavosPharma, based in Upper Saddle River, New Jersey, has been a player in the pharmaceutical services industry since its founding in 1972. Originally established as Davos Chemical Corporation, the company has evolved to focus on drug discovery and custom cGMP manufacturing. They provide a comprehensive suite of services that includes discovery chemistry, formulation development, and toxicology, catering to clients across the pharmaceutical and biotechnology sectors. DavosPharma prides itself on its results-oriented approach, where payment is contingent on deliverables, ensuring accountability and performance. The company has successfully managed numerous projects, including over 80 INDs filed in a recent year, showcasing their active involvement in advancing drug candidates through the development pipeline. Their expertise extends to both small molecules and biologics, making them a versatile partner for various drug development needs.
14. ProBio
- Website: probiocdmo.com
- Ownership type: Venture Capital
- Headquarters: Pennington, New Jersey, United States (USA)
- Employee distribution: United States (USA) 57%, China 38%, South Korea 4%, Other 2%
- Latest funding: Series C, $220.0M, January 2023
- Founded year: 2020
- Headcount: 201-500
- LinkedIn: genscript-probio
ProBio, based in Pennington, New Jersey, is a biologics contract development and manufacturing organization (CDMO) that specializes in providing end-to-end services for drug discovery and commercialization. Founded in 2020, ProBio has quickly made a name for itself by offering a range of solutions that include antibody discovery, cell line development, and clinical manufacturing. The company primarily serves biopharmaceutical companies and research institutions, helping them navigate the complexities of biologics development and regulatory compliance. ProBio operates on a global scale, with a significant presence in the United States, China, and South Korea. As of January 2023, ProBio secured $220 million in Series C funding, reflecting strong investor interest and confidence in its business model. The company has facilitated over 90 IND approvals since its inception, showcasing its capability to support clients through the drug development process. ProBio's commitment to quality and efficiency is underscored by its proprietary Phase-appropriate Compliance (PAC) quality system, which meets stringent regulatory standards across multiple regions.
15. Antares Pharma Inc.
- Website: antarespharma.com
- Ownership type: Corporate
- Headquarters: Ewing Township, New Jersey, United States (USA)
- Employee distribution: United States (USA) 100%
- Latest funding: $960.0M, April 2022
- Founded year: 1979
- Headcount: 51-200
- LinkedIn: antares-pharma-inc-
Antares Pharma Inc. is a biotechnology company based in Ewing Township, New Jersey, founded in 1979. The company specializes in innovative drug delivery technologies, particularly focusing on enhancing patient experiences through its proprietary solutions. One of their key technologies, ENHANZE®, facilitates rapid drug administration by allowing for subcutaneous delivery of medications, which can significantly reduce the time and complexity of treatment protocols. Antares Pharma has developed a range of products that leverage this technology, aiming to improve patient outcomes and streamline healthcare processes. The company has also received substantial funding, with a reported amount of $960 million in 2022, indicating strong investor confidence and ongoing development efforts in the biotechnology field.
16. Mitsubishi Tanabe Pharma America
- Website: mt-pharma-america.com
- Ownership type: Private
- Headquarters: Jersey City, New Jersey, United States (USA)
- Employee distribution: United States (USA) 98%, Other 2%
- Founded year: 2016
- Headcount: 51-200
- LinkedIn: mitsubishi-tanabe-pharma-america
Mitsubishi Tanabe Pharma America, based in Jersey City, New Jersey, is a pharmaceutical company that specializes in developing innovative therapies for serious diseases, including amyotrophic lateral sclerosis (ALS) and Parkinson's disease. Founded in 2016, the company is a subsidiary of Mitsubishi Tanabe Pharma Corporation, which has a long history of medical advancements spanning over 300 years. Mitsubishi Tanabe Pharma America is dedicated to addressing unmet medical needs through rigorous research and development efforts. Their focus on ALS is particularly notable, as they have invested in clinical trials and partnerships aimed at discovering new treatment options. The company is also involved in presenting data at various medical conferences, showcasing their commitment to advancing scientific knowledge and improving patient outcomes. With a workforce of approximately 285 employees, Mitsubishi Tanabe Pharma America is actively contributing to the biotechnology industry by providing healthcare providers and patients with effective therapeutic options.
17. LinusBio
- Website: linusbio.com
- Ownership type: Venture Capital
- Headquarters: North Brunswick Township, New Jersey, United States (USA)
- Employee distribution: United States (USA) 86%, United Kingdom (UK) 7%, United Arab Emirates 7%
- Latest funding: $6.1M, August 2024
- Founded year: 2020
- Headcount: 11-50
- LinkedIn: linusbio
LinusBio is a biotechnology firm based in North Brunswick Township, New Jersey, founded in 2020. The company specializes in precision exposome medicine, which seeks to understand how environmental exposures affect health at a molecular level. Their flagship product, StrandDx™ASD, is a non-invasive diagnostic tool designed to aid in the early detection of Autism Spectrum Disorder. LinusBio's technology utilizes temporal exposomic sequencing, allowing for a detailed analysis of an individual's biological response to environmental factors over time. This innovative approach aims to identify biomarkers for various complex health conditions, including CNS disorders and gastrointestinal issues. The company has attracted substantial venture capital funding, with recent rounds totaling over $16 million, which supports their ongoing research and development efforts. LinusBio's commitment to addressing significant gaps in diagnostic capabilities makes it a noteworthy player in the biotechnology sector.
18. Prolong Pharmaceuticals
- Website: prolongpharma.com
- Ownership type: Venture Capital
- Headquarters: South Plainfield, New Jersey, United States (USA)
- Employee distribution: United States (USA) 100%
- Latest funding: $30.0M, October 2010
- Founded year: 2005
- Headcount: 51-200
- LinkedIn: prolong-pharmaceuticals
Prolong Pharmaceuticals, founded in 2005 and based in South Plainfield, New Jersey, is a clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics for complex diseases. The company specializes in addressing unmet medical needs, particularly in the fields of ischemia, hypoxia, sickle cell disease, and cystic fibrosis. Prolong's expertise is rooted in PEGylation technology, which enhances the efficacy and safety of therapeutic proteins. Their lead product, PP-007 (Sanguinate®), is a PEGylated carboxyhemoglobin designed to improve oxygen delivery in hypoxic conditions. Prolong has completed multiple clinical trials, treating over 250 individuals, and has established a robust pipeline aimed at tackling severe and life-threatening conditions. The company operates a large-scale cGMP manufacturing facility, underscoring its commitment to advancing biopharmaceutical development.
19. Eisai US
- Website: us.eisai.com
- Ownership type: Private
- Headquarters: Nutley, New Jersey, United States (USA)
- Employee distribution: United States (USA) 89%, Other 11%
- Founded year: 1995
- Headcount: 1001-5000
- LinkedIn: eisai
Eisai US, based in Nutley, New Jersey, is a pharmaceutical company that specializes in creating innovative treatments for oncology and neurology. Founded in 1995, the company operates with a workforce of approximately 2,955 employees. Eisai US is dedicated to addressing the needs of patients and healthcare providers through its extensive product offerings and ongoing clinical trials. Their commitment to human health care is evident in their active community involvement and patient support initiatives, such as the Magnolia Patient Support Programs and the Eisai USA Foundation. The company is also recognized for its contributions to research, with a global pipeline that targets challenging diseases. Eisai US has received accolades for its influence and innovation in the industry, further solidifying its role as a significant player in the biotechnology field.
20. MedChemExpress LLC
- Website: medchemexpress.com
- Ownership type: Private
- Headquarters: South Brunswick Township, New Jersey, United States (USA)
- Employee distribution: United States (USA) 26%, China 24%, United Kingdom (UK) 12%, Other 37%
- Founded year: 2009
- Headcount: 1001-5000
- LinkedIn: medchemexpress-llc
MedChemExpress LLC, founded in 2009 and based in South Brunswick Township, New Jersey, is a biotechnology company that specializes in the provision of a wide array of bioactive molecules, inhibitors, and screening libraries. Their products are primarily aimed at supporting research and development in the life sciences, catering to a clientele that includes pharmaceutical companies and academic institutions. These entities utilize MedChemExpress's offerings for drug discovery and various scientific applications. The company also provides custom synthesis services, allowing clients to obtain tailored solutions for their specific research needs. With a workforce of around 99 employees, MedChemExpress has a significant presence in the biotechnology sector, with a notable distribution of employees across the United States, China, the United Kingdom, India, and Germany. Their commitment to supporting drug discovery and research initiatives underscores their relevance in the biotechnology industry.
Biotechnology Companies Insights: Key Companies in New Jersey
| Company | Headquarter | Size | Founded | Ownership |
|---|---|---|---|---|
| Kedrion Biopharma | Fort Lee, New Jersey, United States (USA) | 1001-5000 | 2001 | Private Equity |
| NPS Pharma | Bedminster, New Jersey, United States (USA) | 201-500 | 1986 | Corporate |
| CSL Seqirus | Summit, New Jersey, United States (USA) | 1001-5000 | 1916 | Private |
| Anima Biotech | Bernardsville, New Jersey, United States (USA) | 51-200 | 2014 | Corporate |
| Porton Advanced | ATMP CDMO/CRO | Cranbury, New Jersey, United States (USA) | 201-500 | 2018 | Private Equity |
| Celltrion USA | Jersey City, New Jersey, United States (USA) | 51-200 | 2018 | Private |
| Venenum BioDesign, LLC | Hamilton Township, New Jersey, United States (USA) | 11-50 | 2009 | Private |
| Mestastop Solutions | Evesham, New Jersey, United States (USA) | 11-50 | 2018 | Venture Capital |
| Janssen Research & Development, LLC | Raritan, New Jersey, United States (USA) | 1001-5000 | 2001 | Private |
| NS Pharma, Inc. | Paramus, New Jersey, United States (USA) | 51-200 | 1999 | Private |
| Genesis Global Group | Hamilton Township, New Jersey, United States (USA) | 501-1000 | 2020 | Private |
| Kedrion Biopharma US | Fort Lee, New Jersey, United States (USA) | 1001-5000 | 2011 | Family Owned |
| DavosPharma | Upper Saddle River, New Jersey, United States (USA) | 11-50 | 1972 | Private |
| ProBio | Pennington, New Jersey, United States (USA) | 201-500 | 2020 | Venture Capital |
| Antares Pharma Inc. | Ewing Township, New Jersey, United States (USA) | 51-200 | 1979 | Corporate |
| Mitsubishi Tanabe Pharma America | Jersey City, New Jersey, United States (USA) | 51-200 | 2016 | Private |
| LinusBio | North Brunswick Township, New Jersey, United States (USA) | 11-50 | 2020 | Venture Capital |
| Prolong Pharmaceuticals | South Plainfield, New Jersey, United States (USA) | 51-200 | 2005 | Venture Capital |
| Eisai US | Nutley, New Jersey, United States (USA) | 1001-5000 | 1995 | Private |
| MedChemExpress LLC | South Brunswick Township, New Jersey, United States (USA) | 1001-5000 | 2009 | Private |
Want to Find More Biotechnology Companies Companies?
If you want to find more companies that offer innovative therapies, advanced drug development, and research solutions you can do so with Inven. This list was built with Inven and there are hundreds of companies like these globally.With Inven you'll also get to know the company's:- Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
- Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
- Financials: How do these companies perform financially? What are their revenues and profit margins?
...and a lot more!
.jpg)
Trusted by 700+ companies
